4L7-26945-79333
2 vaccinations
1 coded response
20 check-ins
1 free-text entry
0 call cases
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 800 / CO
- Registered
- 2022-07-13
- Relationship
- Child or adolescent in my care
- Guardian
- LEL-29869-98936
- Race
- Multiracial
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-07-12
Dose 1 — Pfizer-BioNTech
-
2022-07-13
Registered in v-safe
- 2022-07-13
- 2022-07-14
- 2022-07-15
- 2022-07-16
- 2022-07-17
- 2022-07-18
- 2022-07-19
- 2022-07-26
- 2022-08-02
-
2022-08-08
Dose 2 — Pfizer-BioNTech
-
2022-08-11
Health check-in — days 1–6 daily, dose 2, under 3Feeling: Good · Sleepiness, DiarrheaUnder 3 check-in
- 2022-08-13
- 2022-08-14
- 2022-08-17
- 2022-08-22
-
2022-08-29
Survey response — day 21, dose 2, under 3MedDRA: Eczema, Pre-existing disease — Feeling: FairFree text: Eczema flareMedDRA releases: 2024-11 · check-in free text available
- 2022-09-05
- 2022-09-12
- 2022-09-19
- 2022-11-07
- 2023-02-06
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-07-12 | Pfizer-BioNTech | No |
| 2 | 2022-08-08 | Pfizer-BioNTech | No |
Free text
Release 12 (Under 3) — day 21, dose 2, under 3
Symptoms: Eczema flare
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Eczema | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release